Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q2 2016 call → NOWe need to determine if management conveys that the business is visibly outgrowing the company's own current size and setup. Look for statements about current activity, demand, commitments arriving at a scale large relative to the company's small size. The transcript has management comments. Yaki says: "We see strong momentum in the business and this is now the third quarter in a row of going both license and total revenues with 30% or more year-over-year." That indicates growth but not necessarily disproportion. He says "More and more organizations realize that they don't have visibility into the massive and growing stores of unstructured data... So many of these digital assets are sensitive and valuable far more than many realize... Therefore the management in protection of unstructured data in prior systems are becoming key spending priorities... We are also benefiting from trends in UBA... This means that more and more companies realize that they need Varonis first." That's about market trends, not necessarily about the company being small relative to what's arriving. He says "We know, that the problems we are trying to solve are bigger and getting bigger." That's a general statement. He mentions a study of 3,000 IT professionals, but that's market data. He says "Our pipeline is ongoing and we're experiencing less friction in the sales cycle as buyers understand what we do and the need for software." That's about sales cycle, not disproportion. He says "We have capitalized on this increased interest and see return of our investment. During Q1 and Q2 we conducted 23 worldwide Varonis Connect events and attendance nearly doubled compared to the same period in 2015." That's about events, not necessarily scale relative to company size. He says "Our insider threat complaints generate awareness in web traffic and our trial and demo requests nearly doubled during the first half of this year compared to the first half of last year." That's growth, but not necessarily disproportion. He says "We are pleased with our execution. We are benefiting from our exports to build awareness around solutions and taking advantage of key trends that drive security spending and data protection. Overall, demand remains very positive and we believe that we will continue to capitalize on the various spend moving in our direction." That's general.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.